The Cooper Companies, Inc.: stock overview

COONASDAQHealthcare · Ophthalmic Goods

Price

$62.65

November 13, 2026Market cap $12.3B

What Ploutos Investor adds for Cooper Companies

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from FY2009
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

In short

Cooper Companies had revenue of $4.2B over the last 12 months and net income of $570M, a net margin of 13.5%. Revenue grew by 11.0% a year on average over the last 5 years. At $62.65 the shares trade at a P/E of 21.5, against a median of 37.4 over the last 5 fiscal years. It has net debt of $2.4B. It pays no dividend.

From its SEC filings (latest fiscal year to October 31, 2025) and the price of November 13, 2026.

Its SEC filings
Market cap
$12.3B
196M shares
P/E
21.5
Today21.5
Median37.4
Revenue, 12 months
$4.2B
+11.0% a year over 5 years
Net margin
13.5%
FY2025: 9.2%, above 69% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

FY2023–FY2025 fiscal years

+6.7% a year over 2 years

  • FY2025Oct 31, 202510-K
    Revenue$4.1B
  • FY2024Oct 31, 202410-K
    Revenue$3.9B
  • FY2023Oct 31, 202310-K
    Revenue$3.6B

Fiscal years in figures

COO's revenue, profit, cash flow and dividend with each year-end price, from FY2009 to FY2022, 14 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $15.4B
$12.3B
Enterprise value 
$14.7B
P/E 3-year median: 52.7
21.5
EV / EBIT 
27.0
EV / Revenue 
3.5
P/B 3-year median: 2.0
1.5
FCF yield 3-year median: 1.4%
5.5%
Earnings yield 3-year median: 1.9%
4.6%

Profitability

Gross margin 
65.9%
Operating margin 
12.8%
Net margin 3-year median: 9.2%
13.5%
ROIC 
4.0%
ROIC, 5-year average 
4.6%
ROE 
6.9%

Growth

Revenue, yearly change 
+5.1%
EPS, yearly change 
-4.6%
FCF, yearly change 
+50.5%
Revenue, average a year 
+11.0%
EPS, average a year 
+9.2%

The yearly change compares FY2025 with FY2024.

Balance sheet

Cash 
$155M
Total debt 
$2.5B
Net debt 
$2.4B
Net debt / EBITDA 
2.6x
Interest cover 
6.1x
Current ratio 
1.22

Balance sheet of July 31, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
2.36%
Total returned 
2.36%
Shares, yearly change 
-1.8%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 38).

Gross margin

65.5%

Above 69% of the 161 companies in its industry, and 83% of all.

Operating margin

16.7%

Above 77% of the 186 companies in its industry, and 77% of all.

Net margin

9.2%

Above 69% of the 189 companies in its industry, and 64% of all.

ROE

4.5%

Above 56% of the 174 companies in its industry, and 41% of all.

ROA

3.0%

Above 59% of the 190 companies in its industry, and 61% of all.

Revenue growth

5.1%

Above 40% of the 186 companies in its industry, and 46% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
COOPER COMPANIES, INC.
Exchange
NASDAQ
Industry (SIC)
3851 · Ophthalmic Goods
Fiscal year ends
October 31
Latest annual report
October 31, 2025
Reporting currency
USD
Shares
196M

Other companies: Healthcare

The largest companies of the same sector, each with its own page.

The Healthcare sectorAll companies

The full analysis

What do Cooper Companies's filings show?

These are Cooper Companies's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about COO

Didn't find what you were looking for?

Ask us
What is COO's market cap?

The Cooper Companies, Inc.'s market cap is $12.3B, at a price of $62.65 on November 13, 2026 and 196M shares.

What is COO's P/E?

COO's P/E is 21.5, on earnings per share of $2.92 over the last 12 months. The median over the last 5 fiscal years was 37.4.

How much revenue does COO have?

Cooper Companies had revenue of $4.2B over the last 12 months. Over the last 5 years it changed by +11.0% a year on average.

Does COO pay a dividend?

No. Cooper Companies paid no regular dividend over the last 12 months.

Where do the figures come from?

From The Cooper Companies, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.